New Director For Free Software Foundation
The Free Software Foundation (FSF) has announced the appointment of a new executive director.
Original news and analysis on international IP policy
The Free Software Foundation (FSF) has announced the appointment of a new executive director.
The new international agreement on access and benefit-sharing of genetic resources has many IP implications, according to panellists at an event last week. And at least one United Nations agency is launching an effort to help countries with those IP implications.
Recent events in the Arab region have brought the issue of access to the internet and social platforms sharply into the spotlight as governments have tried to block or limit internet access and cut millions of people from communication. A United States-hosted panel discussion in Geneva yesterday brought together representatives of Google, Facebook, and Access, a civil society group defending digital freedom.
Country experts this week took up the challenge of doing the groundwork for negotiations towards a treaty on the protection of genetic resources at the World Intellectual Property Organization. Breaking uncharacteristically early on the final day today, the experts’ work delivered a set of options reflecting all points of views for negotiators to work from.
A new draft document was issued yesterday by a drafting group of experts at the World Intellectual Property Organization. The drafting group was in charge of cleaning up a text with aspirations to become a draft international instrument on the protection of genetic resources, and added a number of options for a possible treaty.
World Trade Organization members on Thursday combed through a composite text displaying the different views on a mandated multilateral system of notification and registration of geographical indications on wines and spirits. The composite text was developed last week as the result of several informal meetings. Countries now have clarified their inputs to the document and tried to define what next steps should be taken to refine it, but discussions were difficult, according to participants.
After three days of intense negotiations on the role of the World Health Organization in the fight against low standard or falsified medicines, delegates provided recommendations for the UN agency. A subject of dissent was the relationship between the WHO and its taskforce against counterfeit medicines, with some countries calling for a suspension of the taskforce’s work, though in the end no consensus was found.
Myriad Genetics, a United States-based biotechnology company with exclusive patent rights over a key breast cancer diagnostic test in the US, may shift its patent strategy from its inventions to protecting its data in the face of drawn out litigation and upcoming competition, an industry journal has reported.
Patentable subject matter was discussed this week at the World Trade Organization with entrenched positions, according to sources, and the momentum started in October on ways to improve a public health exception within the WTO Trade-Related Aspects of Intellectual Property Rights (TRIPS) agreement, appeared to have lost some steam.
Public input is being sought this week for an external review of technical assistance provided by the World Intellectual Property Organization (WIPO). For years, questions have been raised over the fairness and appropriateness of the guidance and training provided to developing countries by WIPO provides, the UN agency whose aim is to promote protection of IP rights.
The role of the World Health Organization in the safety, quality and efficacy of medical products is under scrutiny this week by member states and stakeholders. In particular, the focus is on the WHO’s role in the prevention and control of medical products of compromised quality, the organisation’s relationship with the international taskforce against counterfeit products, and the taskforce’s alleged focus on the protection of intellectual property rights rather than on public health issues. In several documents, the WHO tries to explain this fragile role.
Experts discussing the protection of genetic resources at the World Intellectual Property Organization this week are struggling to stay within their technical mandate as the issues carry significant political impact. Discussions today resulted in a marked-up text on objectives and principles of a possible international instrument that reveals key differences among members on the role of IP, and of WIPO, in genetic resources.